Invesco’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-812,737
| Closed | -$30.6M | – | 4117 |
|
|
2021
Q1 | $30.6M | Sell |
812,737
-864,645
| -52% | -$21.6M | 0.01% | 1298 |
|
|
2020
Q4 | $28.5M | Buy |
1,677,382
+1,621,028
| +2,877% | +$20.3M | 0.01% | 1245 |
|
|
2020
Q3 | $264K | Sell |
56,354
-105,501
| -65% | -$536K | ﹤0.01% | 3364 |
|
|
2020
Q2 | $987K | Buy |
161,855
+98,442
| +155% | +$406K | ﹤0.01% | 2808 |
|
|
2020
Q1 | $144K | Buy |
63,413
+34,946
| +123% | +$148K | ﹤0.01% | 3490 |
|
|
2019
Q4 | $131K | Sell |
28,467
-1,925
| -6% | -$7.62K | ﹤0.01% | 3587 |
|
|
2019
Q3 | $118K | Sell |
30,392
-1,168
| -4% | -$6.41K | ﹤0.01% | 3616 |
|
|
2019
Q2 | $190K | Sell |
31,560
-13,514
| -30% | -$129K | ﹤0.01% | 3625 |
|
|
2019
Q1 | $604K | Buy |
45,074
+1,493
| +3% | +$17K | ﹤0.01% | 3235 |
|
|
2018
Q4 | $405K | Buy |
43,581
+5,709
| +15% | +$67.9K | ﹤0.01% | 3362 |
|
|
2018
Q3 | $527K | Buy |
37,872
+30
| +0.1% | +$446 | ﹤0.01% | 3406 |
|
|
2018
Q2 | $598K | Buy |
37,842
+10,759
| +40% | +$188K | ﹤0.01% | 3350 |
|
|
2018
Q1 | $465K | Buy |
27,083
+11,919
| +79% | +$233K | ﹤0.01% | 3356 |
|
|
2017
Q4 | $332K | Buy |
15,164
+666
| +5% | +$21.4K | ﹤0.01% | 3421 |
|
|
2017
Q3 | $593K | Buy |
14,498
+226
| +2% | +$7.09K | ﹤0.01% | 3249 |
|
|
2017
Q2 | $430K | Sell |
14,272
-30,477
| -68% | -$951K | ﹤0.01% | 3367 |
|
|
2017
Q1 | $1.62M | Sell |
44,749
-162,152
| -78% | -$7.15M | ﹤0.01% | 2750 |
|
|
2016
Q4 | $10.4M | Buy |
206,901
+32,413
| +19% | +$1.7M | ﹤0.01% | 1518 |
|
|
2016
Q3 | $9.16M | Buy |
174,488
+1,577
| +0.9% | +$75.3K | ﹤0.01% | 1559 |
|
|
2016
Q2 | $7.15M | Buy |
172,911
+98,933
| +134% | +$4.3M | ﹤0.01% | 1653 |
|
|
2016
Q1 | $3.01M | Buy |
+73,978
| New | +$2.54M | ﹤0.01% | 2222 |
|
|
2015
Q3 | – | Sell |
-217
| Closed | -$5K | – | 4101 |
|
|
2015
Q2 | $5K | Buy |
+217
| New | +$4.83K | ﹤0.01% | 4245 |
|
|
2015
Q1 | – | Sell |
-41,683
| Closed | -$1.13M | – | 4096 |
|
|
2014
Q4 | $1.13M | Buy |
+41,683
| New | +$717K | ﹤0.01% | 2885 |
|
Invesco's FPRX Position: Q2 2021 in Review
Invesco sold out of Five Prime Therapeutics, Inc. (FPRX) in Q2 2021, closing a stake of 812,737 shares — an estimated $30.6M sold.
Invesco first reported a position in FPRX in Q4 2014 and held it in 23 quarters. The position peaked at $30.6M in Q1 2021. 0 funds tracked by Wall St. Rank hold FPRX as of Q2 2021.
- Invesco reported no remaining Five Prime Therapeutics, Inc. position as of Q2 2021 after selling out during the quarter.
- Invesco sold 812,737 Five Prime Therapeutics, Inc. shares in Q2 2021, an estimated $30.6M.
- Invesco first reported a position in Five Prime Therapeutics, Inc. in Q4 2014 and held it in 23 quarters.
- Invesco's Five Prime Therapeutics, Inc. position peaked at $30.6M in Q1 2021.
- 0 funds tracked by Wall St. Rank held Five Prime Therapeutics, Inc. as of Q2 2021.
Based on Invesco's 13F filing for Q2 2021, filed 17 Aug 2021.